Abstract
In recent years, there has been a considerable amount of interest in the area of Genomic Signal Processing, which is the engineering discipline that studies the processing of genomic signals. Since regulatory decisions within the cell utilize numerous inputs, analytical tools are necessary to model the multivariate influences on decision-making produced by complex genetic networks. Signal processing approaches such as detection, prediction and classification have been used in the recent past to construct genetic regulatory networks capable of modeling genetic behavior. To accommodate the large amount of uncertainty associated with this kind of modeling, many of the networks proposed are probabilistic. One of the objectives of network modeling is to use the network to design different intervention approaches for affecting the time evolution of the gene activity profile of the network. More specifically, one is interested in intervening to help the network avoid undesirable states such as those associated with a disease. This paper provides a tutorial survey of the intervention approaches developed so far in the literature for probabilistic gene networks (probabilistic Boolean networks) and outlines some of the open challenges that remain.
Keywords: Gene regulatory network, markov chain, steady-state distribution, optimal control, dynamic programming, context sensitive networks
Current Bioinformatics
Title: Intervention in Probabilistic Gene Regulatory Networks
Volume: 1 Issue: 2
Author(s): Aniruddha Datta, Ranadip Pal and Edward R. Dougherty
Affiliation:
Keywords: Gene regulatory network, markov chain, steady-state distribution, optimal control, dynamic programming, context sensitive networks
Abstract: In recent years, there has been a considerable amount of interest in the area of Genomic Signal Processing, which is the engineering discipline that studies the processing of genomic signals. Since regulatory decisions within the cell utilize numerous inputs, analytical tools are necessary to model the multivariate influences on decision-making produced by complex genetic networks. Signal processing approaches such as detection, prediction and classification have been used in the recent past to construct genetic regulatory networks capable of modeling genetic behavior. To accommodate the large amount of uncertainty associated with this kind of modeling, many of the networks proposed are probabilistic. One of the objectives of network modeling is to use the network to design different intervention approaches for affecting the time evolution of the gene activity profile of the network. More specifically, one is interested in intervening to help the network avoid undesirable states such as those associated with a disease. This paper provides a tutorial survey of the intervention approaches developed so far in the literature for probabilistic gene networks (probabilistic Boolean networks) and outlines some of the open challenges that remain.
Export Options
About this article
Cite this article as:
Datta Aniruddha, Pal Ranadip and Dougherty R. Edward, Intervention in Probabilistic Gene Regulatory Networks, Current Bioinformatics 2006; 1 (2) . https://dx.doi.org/10.2174/157489306777011978
DOI https://dx.doi.org/10.2174/157489306777011978 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CXCR1/2 Chemokine Network Regulates Melanoma Resistance to Chemotherapies Mediated by NF-κB
Current Molecular Medicine Treating Age-Related Macular Degeneration – Interaction of VEGF-Antagonists with their Target
Mini-Reviews in Medicinal Chemistry Emergence of Ad-Mediated Combination Therapy Against Cancer: What to Expect?
Current Cancer Drug Targets Genetically Engineered Elastin-based Biomaterials for Biomedical Applications
Current Medicinal Chemistry Recent Advances in the Synthesis and Anticancer Activity of Some Molecules Other Than Nitrogen Containing Heterocyclic Moeities
Mini-Reviews in Medicinal Chemistry Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Current Pharmaceutical Biotechnology Humans Entrain to Sunlight - Impact of Social Jet Lag on Disease and Implications for Critical Illness
Current Pharmaceutical Design Melanocortins in the Treatment of Male and Female Sexual Dysfunction
Current Topics in Medicinal Chemistry Protective Role of Natural Products in Glioblastoma Multiforme: A Focus on Nitric Oxide Pathway
Current Medicinal Chemistry Concentrations of Cd, Cu, Pb and Zn in Blood Serum of Cancer Patients and Comparison with Healthy Person by Atomic Absorption Spectrometry
Current Analytical Chemistry C6-Ceramide-Coated Catheters Promote Re-Endothelialization of Stretch- Injured Arteries
Vascular Disease Prevention (Discontinued) Angiogenesis Inhibitors and Radiation in Multimodality Cancer Therapy: Preclinical and Clinical Studies
Current Angiogenesis (Discontinued) Plant Secondary Metabolites in Cancer Chemotherapy: Where are We?
Current Pharmaceutical Biotechnology Regulation of Angiogenesis by Th1- and Th2-Type Cytokines
Current Pharmaceutical Design Induction of Divergent Cell Death Pathways by Urea and Carbohydrazide Derivatives
Anti-Cancer Agents in Medicinal Chemistry Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors
Recent Patents on Anti-Cancer Drug Discovery Meridianins: Marine-Derived Potent Kinase Inhibitors
Mini-Reviews in Medicinal Chemistry Pentacyclic Triterpenoids and Their Saponins with Apoptosis-Inducing Activity
Current Topics in Medicinal Chemistry Effect of Botanicals on Inflammation and Skin Aging: Analyzing the Evidence
Inflammation & Allergy - Drug Targets (Discontinued) An Evolving Role of Piperazine Moieties in Drug Design and Discovery
Mini-Reviews in Medicinal Chemistry